We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analgesia After Cesarean Section

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01360060
First Posted: May 25, 2011
Last Update Posted: May 25, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Seoul National University Bundang Hospital
May 17, 2011
May 25, 2011
May 25, 2011
December 2010
March 2011   (Final data collection date for primary outcome measure)
Change of numeric rating scale (NRS) of postoperative pain during postoperative period [ Time Frame: postoperative 1, 2, 3, and 4 day ]
Same as current
No Changes Posted
  • incidence of stopping of intravenous PCA during postoperative 4 days [ Time Frame: during postoperative 4 days ]
  • serum magnesium level of group P [ Time Frame: preoperative 1 h and postoperative 1 day ]
Same as current
Not Provided
Not Provided
 
Analgesia After Cesarean Section
Not Provided
Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
medical record review
  • Preeclampsia
  • Pregnancy
Drug: Magnesium Sulphate
Magnesium sulphate was infused for the management of preeclampsia at perioperative period.
  • Group N
    parturients who had undergone Cesarean section under the diagnosis of non-preeclampsia
  • Group P
    parturients who had undergone Cesarean section under the diagnosis of preeclampsia
    Intervention: Drug: Magnesium Sulphate
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
503
March 2011
March 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • parturients undergoing Cesarean section
Sexes Eligible for Study: Female
20 Years to 50 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT01360060
Mg_section
Not Provided
Not Provided
Not Provided
Hyoseok, Na/professor, Seoul National University Bundang Hospital
Seoul National University Bundang Hospital
Not Provided
Not Provided
Seoul National University Bundang Hospital
May 2011